TP53 and neoplasm: Further analysis of ten tumor-related pathways revealed significantly higher mutation frequencies in the Hippo (P = 0.011), NOTCH (P = 0.013), and TP53 (P = 0.011) pathways in the HAS-group compared to the LAS-group (Figures 2D, F; Supplementary Figure S4B).